These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 18718080)
1. [Expression and function of non-muscle myosin-IIA in Fechtner syndrome]. Yang HY; Wang ZY; Cao LJ; Zhao XJ; Bai X; Ruan CG Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):871-4. PubMed ID: 18718080 [TBL] [Abstract][Full Text] [Related]
2. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease. Marini M; Bruschi M; Pecci A; Romagnoli R; Musante L; Candiano G; Ghiggeri GM; Balduini C; Seri M; Ravazzolo R Int J Mol Med; 2006 May; 17(5):729-36. PubMed ID: 16596254 [TBL] [Abstract][Full Text] [Related]
3. Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes. D'Apolito M; Guarnieri V; Boncristiano M; Zelante L; Savoia A Gene; 2002 Mar; 286(2):215-22. PubMed ID: 11943476 [TBL] [Abstract][Full Text] [Related]
4. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders]. Kunishima S Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439 [TBL] [Abstract][Full Text] [Related]
6. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations. Kunishima S; Yoshinari M; Nishio H; Ida K; Miura T; Matsushita T; Hamaguchi M; Saito H Eur J Haematol; 2007 Mar; 78(3):220-6. PubMed ID: 17241369 [TBL] [Abstract][Full Text] [Related]
7. Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. Pecci A; Noris P; Invernizzi R; Savoia A; Seri M; Ghiggeri GM; Sartore S; Gangarossa S; Bizzaro N; Balduini CL Br J Haematol; 2002 Apr; 117(1):164-7. PubMed ID: 11918549 [TBL] [Abstract][Full Text] [Related]
8. Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression. Bluteau D; Glembotsky AC; Raimbault A; Balayn N; Gilles L; Rameau P; Nurden P; Alessi MC; Debili N; Vainchenker W; Heller PG; Favier R; Raslova H Blood; 2012 Sep; 120(13):2708-18. PubMed ID: 22898599 [TBL] [Abstract][Full Text] [Related]
9. Defective expression of GPIb/IX/V complex in platelets from patients with May-Hegglin anomaly and Sebastian syndrome. Di Pumpo M; Noris P; Pecci A; Savoia A; Seri M; Ceresa IF; Balduini CL Haematologica; 2002 Sep; 87(9):943-7. PubMed ID: 12217806 [TBL] [Abstract][Full Text] [Related]
10. Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome). Ghiggeri GM; Caridi G; Magrini U; Sessa A; Savoia A; Seri M; Pecci A; Romagnoli R; Gangarossa S; Noris P; Sartore S; Necchi V; Ravazzolo R; Balduini CL Am J Kidney Dis; 2003 Jan; 41(1):95-104. PubMed ID: 12500226 [TBL] [Abstract][Full Text] [Related]
11. Establishment of mouse model of MYH9 disorders: heterozygous R702C mutation provokes macrothrombocytopenia with leukocyte inclusion bodies, renal glomerulosclerosis and hearing disability. Suzuki N; Kunishima S; Ikejiri M; Maruyama S; Sone M; Takagi A; Ikawa M; Okabe M; Kojima T; Saito H; Naoe T; Matsushita T PLoS One; 2013; 8(8):e71187. PubMed ID: 23976996 [TBL] [Abstract][Full Text] [Related]
12. [May-Hegglin anomaly: past and present--novel diagnostic test and new concept of the disease]. Kunishima S Rinsho Byori; 2009 Jan; 57(1):54-9. PubMed ID: 19227191 [TBL] [Abstract][Full Text] [Related]
13. Distinct roles of nonmuscle myosin II isoforms in the regulation of MDA-MB-231 breast cancer cell spreading and migration. Betapudi V; Licate LS; Egelhoff TT Cancer Res; 2006 May; 66(9):4725-33. PubMed ID: 16651425 [TBL] [Abstract][Full Text] [Related]
14. Mutations in human nonmuscle myosin IIA found in patients with May-Hegglin anomaly and Fechtner syndrome result in impaired enzymatic function. Hu A; Wang F; Sellers JR J Biol Chem; 2002 Nov; 277(48):46512-7. PubMed ID: 12237319 [TBL] [Abstract][Full Text] [Related]
15. Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease. Verver EJ; Topsakal V; Kunst HP; Huygen PL; Heller PG; Pujol-Moix N; Savoia A; Benazzo M; Fierro T; Grolman W; Gresele P; Pecci A Ear Hear; 2016; 37(1):112-20. PubMed ID: 26226608 [TBL] [Abstract][Full Text] [Related]
16. Ultrastructural analysis of granulocyte inclusions in genetically confirmed MYH9-related disorders. Pujol-Moix N; Kelley MJ; Hernández A; Muñiz-Diaz E; Español I Haematologica; 2004 Mar; 89(3):330-7. PubMed ID: 15020273 [TBL] [Abstract][Full Text] [Related]
17. Asymmetric distribution of myosin IIB in migrating endothelial cells is regulated by a rho-dependent kinase and contributes to tail retraction. Kolega J Mol Biol Cell; 2003 Dec; 14(12):4745-57. PubMed ID: 12960430 [TBL] [Abstract][Full Text] [Related]
19. Distinct roles for non-muscle myosin II isoforms in mouse hepatic stellate cells. Liu Z; Van Rossen E; Timmermans JP; Geerts A; van Grunsven LA; Reynaert H J Hepatol; 2011 Jan; 54(1):132-41. PubMed ID: 20932596 [TBL] [Abstract][Full Text] [Related]
20. The distinct roles of myosin IIA and IIB under compression stress in nucleus pulposus cells. Ke W; Wang B; Hua W; Song Y; Lu S; Luo R; Li G; Wang K; Liao Z; Xiang Q; Li S; Wu X; Zhang Y; Yang C Cell Prolif; 2021 Feb; 54(2):e12987. PubMed ID: 33415745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]